Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Loxo Oncology, Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 23.82||$ 35|
|Low||$ 22.48||$ 10.71|
The current last sale of $23.12 is 115.87% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
Loxo Oncology is a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers. Our pipeline focuses on cancers that are uniquely dependent on single gene abnormalities, such that a single drug has the potential to treat the cancer with dramatic effect. We believe that the most selective, purpose-built medicines have the highest probability of maximally inhibiting the intended target, thereby delivering best-in-class disease control and safety. Our management team seeks out experienced industry partners, world-class scientific advisors and innovative clinical-regulatory approaches to deliver new cancer therapies to patients as quickly and efficiently as possible. As genetic testing in cancer becomes more routine, we are learning that cancers arising in diverse sites in the body may share the same type of genetic alterations. ... More ...
Where does LOXO fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$-2.12|
|Quarterly EPS Est:||-0.7|